Role of Helicobacter Pylori in treatment of fatty liver

Not Applicable

• Conditions: Condition 1: Nonalcoholic fatty liver disease. Condition 2: Helicobacter pylori infection.; Fatty (change of) liver, not elsewhere classified; Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters

• Registration Number: IRCT2015042020951N2
• Lead Sponsor: research department of medical college of QUMS

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Inclusion Criteria: Helicobacter Pylori Infection according to serologic test; Non-alcoholic fatty liver disease according to liver function tests and sonography; consent to participation in the study.
Exclusion criteria: presence of any other medical disease; history of hypersensitivity to the prescribed drugs; non-consent to the participation to the study

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Aspartate aminotransferase. Timepoint: at the start and end of the study. Method of measurement: by clinical labratory.;Alanine aminotransferase. Timepoint: at the start and end of the study. Method of measurement: by clinical labratory.;Sonographic indices of fatty liver disease. Timepoint: at the start and end of the study. Method of measurement: by a trained sonologist.